Grafting of cell-penetrating peptide to receptor-targeted liposomes improves their transfection efficiency and transport across blood-brain barrier model

Journal of Pharmaceutical Sciences

Volumn 101, Issue 7, 2012, Pages 2468-2478

  Sharma, Gitanjali ^a   Modgil, Amit ^a   Sun, Chengwen ^a   Singh, Jagdish ^a  

^a NORTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

Biocompatibility; Blood brain barrier; Gene delivery; Liposomes; Nanotechnology

Indexed keywords

CHLOROFORM; LIPOSOME; MACROGOL; METHANOL; PHOSPHOETHANOLAMINE; PHOSPHOLIPID; POLYARGININE; TRANSFERRIN; CELL PENETRATING PEPTIDE; MACROGOL DERIVATIVE; PEPTIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; DRUG TRANSPORT; ENDOTHELIUM CELL; GENE DELIVERY SYSTEM; GLIA CELL; HYDRATION; IN VITRO STUDY; NONHUMAN; RAT; ANIMAL; CHEMISTRY; GENETIC TRANSFECTION; GLIA; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; CELL-PENETRATING PEPTIDES; CELLS, CULTURED; LIPOSOMES; NEUROGLIA; PEPTIDES; POLYETHYLENE GLYCOLS; RATS; TRANSFECTION; TRANSFERRIN;

EID: 84866276524     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23152     Document Type: Article

References (48)

1. Foust KD, Nurre E, Montgomery CL, Hernandez A, Chan CM, Kaspar BK. 2009. Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat Biotechnol 27:59-65.
2. Mayurama K. 2011. Intracellular targeting of liposomal drugs to solid tumors based on the EPR effects. Adv Drug Deliv Rev 63:161-169.
3. Amstad E, Kohlbrecher J, Muller E, Schweizer T, Textor M, Reimhult E. 2011. Triggered release from liposomes through magnetic actuation of iron oxide nanoparticle containing membranes. Nano Lett 11:1664-1670.
4. Obata Y, Tajima S, Takeoka S. 2010. Evaluation of pH-responsive liposomes containing amino acid based zwitterionic lipids for improving intracellular drug delivery in vitro and in vivo. J Control Release 142:267-276.
5. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. 2007. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 12:751-760.
6. Bareford LM, Swaan PW. 2007. Endocytic mechanisms for targeted drug delivery. Adv Drug Deliv Rev 59:748-758.
7. Nakanishi M, Nogichi A. 2001. Confocal and probe microscopy to study gene transfection mediated by cationic liposomes with a cationic cholesterol derivative. Adv Drug Deliv Rev 52:197-207.
8. Almofti MR, Harashima H, Shinohara Y, Almofti A, Baba Y, Kiwada H. 2003. Cationic liposome-mediated gene delivery: Biophysical study and mechanism of internalization. Arch Biochem Biophys 410:246-253.
9. Xu Y, Jr. Szoka FC, 1996. Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection. Biochemistry 35:5616-5623.
10. Vlerken LE, Vyas TK, Amiji MM. 2007. Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery. Pharm Res 24:1405-1414.
11. Okuda T, Kawakami Kawakami S, Akimoto N, Niidome T, Yamashita F, Hashida M. 2006. PEGylated lysine dendrimers for tumor-selective targeting after intravenous injection in tumor-bearing mice. J Control Release 116:330-336.
12. Roux E, Passirani C, Scheffold S, Benoit JP, Leroux JC. 2004. Serum-stable and long-circulating, PEGylated, pH-sensitive liposomes. J Control Release 94:447-451.
13. Hatakeyama H, Akita H, Kogure K, Oishi M, Nagasaki Y, Kihira Y, Ueno M, Kobayashi H, Kikuchi H, Harashima Y. 2007. Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid. Gene Ther 14:68-77.
14. Hatakeyama H, Akita H, Harashima H. 2011. A multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: A strategy for overcoming the PEG dilemma. Adv Drug Deliv Rev 63:152-160.
15. Kibria G, Hatakeyama H, Ohga N, Hida K, Harashima H. 2011. Dual ligand modification of PEGylated liposomes shows better cell selectivity and efficient gene delivery. J Control Release 153:141-148.
16. Huwyler J, Wu D, Pardridge WM. 1996. Brain drug delivery of small molecules using immunoliposomes. Proc Natl Acad Sci USA 93:14164-14169.
17. Oba M, Fukushima S, Kanayama N, Aoyagi K, Nishiyama N, Koyama H, Kataoka K. 2007. Cyclic RGD peptide-conjugated polyplex micelles as a targetable gene delivery system directed to cells possessing alphavbeta3 and alphavbeta5 integrins. Bioconjug Chem 18:1415-1423.
18. Bolhassani A. 2011. Potential efficacy of cell-penetrating peptides for nucleic acid and drug delivery in cancer. Biochim Biophys Acta 1816:232-246.
19. Trabulo S, Cardoso AL, Mano M, de Lima MCP. 2010. Cell-penetrating peptides-Mechanisms of cellular uptake and generation of delivery systems. Pharmaceuticals 3:961-993.
20. Kleemann E, Neu M, Jekel N, Fink L, Schmehl T, Gessler T, Seeger W, Kissel T. 2005. Nanocarriers for DNA delivery to the lung based upon a TAT-derived peptide covalently coupled to PEG-PEI. J Control Release 109:299-316.
21. Kim T, Baek J, Bai CZ, Park JS. 2007. Arginine-conjugated polypropylenimine dendrimer as a non-toxic and efficient gene delivery carrier. Biomaterials 28:2061-2067.
22. Prabhakara K, Afzala SM, Kumarb PU, Rajannab A, Kishana V. 2011. Brain delivery of transferrin coupled indinavir submicron lipid emulsions-Pharmacokinetics and tissue distribution. Colloids Surf B 86:305-313.
23. Zhong MQ, Hongyan L, Hongzhe U, Kwokping H. 2002. Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol Rev 54:561-587.
24. Cheng Y, Zak O, Alsen P, Harrison SC, Watz T. 2004. Structure of the human transferrin receptor-transferrin complex. Cell 116:565-576.
25. Kim HK, Davaa E, Myung CS, Park JS. 2010. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid. Int J Pharm 392:141-147.
26. Visser CC, Stevanovi S, Voorwinden LH, Bloois LV, Gaillard PJ, Danhof M, Crommelin DJA, Boer AG. 2005. Targeting liposomes with protein drugs to the blood-brain barrier in vitro. Eur J Pharm Sci 25:299-305.
27. Li XM, Ding LY, Wang Y, Ping QN. 2009. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin. Int J Pharm 373:116-123.
28. Anabousia S, Laueb M, Lehra CM, Bakowskyc U, Ehrhardta C. 2000. Assessing transferrin modification of liposomes by atomic force microscopy and transmission electron microscopy. Eur J Pharm Sci 11:S81-S91.
29. Nakanoa K, Tozuka Y, Yamamotob H, Kawashima Y, Takeuchi H. 2008. A novel method for measuring rigidity of submicron-size liposomes with atomic force microscopy. Int J Pharm 355:203-209.
30. Zhang HW, Zhang L, Sun X, Zhang ZR. 2007. Successful transfection of hepatoma cells after encapsulation of plasmid DNA into negatively charged liposomes. Biotechnol Bioeng 96:118-124.
31. Edmondson JM, Armstrong LS, Martinez AO. 1998. A rapid and simple MTT-based spectrophotometric assay for determining drug sensitivity in monolayer cultures. Methods Cell Sci 11:15-17.
32. Lila ASA, Kizuki S, Doi Y, Suzuki T, Ishida T, Kiwada H. 2009. Oxaliplatin encapsulated in PEG-coated cationic liposomes induces significant tumor growth suppression via a dual-targeting approach in a murine solid tumor model. J Control Release 137:8-14.
33. Erben M, Decker S, Franke H, Galla HJ. 1995. Electrical resistance measurements on cerebral capillary endothelial cells-A new technique to study small surface areas. J Biochem Biophys Methods 30:227-238.
34. Nakagawa S, Deli MA, Kawaguchi H, Shimizudani T, Shimono T, Kittel A, Tanaka K, Niwa M. 2009. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes. Neurochem Int 54:253-263.
35. Veszelka S, Pasztó IM, Farkas AE, Krizbai I, Ngo TK, Niwa M, Abraham CS, Deli MA. 2007. Pentosan polysulfate protects brain endothelial cells against bacterial lipopolysaccharide-induced damages. Neurochem Int 50:219-228.
36. Deli MA, Abraham CS, Kataoka Y, Niwa M. 2005. Permeability studies on in vitro blood-brain barrier models: Physiology, pathology and pharmacology. Cell Mol Neurobiol 25:59-127.
37. Qina Y, Chena H, Yuana W, Kuaia R, Zhanga Q, Xiea F, Zhanga L, Zhanga Z, Liub J, Hea Q. 2011. Liposome formulated with TAT-modified cholesterol for enhancing the brain delivery. Int J Pharm 419:85-95.
38. Gaillard PJ, Voorwinden HV, Nielsen JL, Ivanov A, Atsumi R, Engman H, Rinbom C, De Boer AG, Breimer DD. 2001. Establishment and functional characterization of an in vitro model of the blood-brain barrier comprising a co-culture of brain capillary endothelial cells and astrocytes. Eur J Pharm Sci 12:215-222.
39. Xie Y, Ye L, Zhang X, Cui W, Lou J, Nagai T, Hou X. 2005. Transport of nerve growth factor encapsulated into liposomes across the blood-brain barrier: In vitro and in vivo studies. J Control Release 105:106-119.
40. Fenke H, Galla HJ, Beuckmann CT. 2000. Primary cultures of brain micovessel endothelial cells: A valid and flexible model to study drug transport through the blood-brain barrier in vitro. Brain Res Brain Res Protoc 5:248-256.
41. Skarlatos S, Yoshikawa T, Pardridge WM. 1995. Transport of [125I]transferrin through the rat blood-brain barrier. Brain Res 683:164-171.
42. Iden DL, Allen TM. 2001. In vitro and in vivo comparison of immunoliposomes made by conventional coupling techniques with those made by a new post-insertion approach. Biochim Biophys Acta 1513:207-216.
43. Moreira JN, Ishida T, Gaspar R, Allen TM. 2002. Use of the post-insertion technique to insert peptide ligands into pre-formed stealth liposomes with retention of binding activity and cytotoxicity. Pharm Res 19:265-269.
44. Malina KCK, Cooper I, Teichberg VI. 2009. Closing the gap between the in-vivo and in-vitro blood-brain barrier tightness. Brain Res 1284:12-21.
45. Tontsch U, Bauer HC. 1991. Glial cells and neurons induce blood-brain barrier related enzymes in cultures cerebral endothelial cells. Brain 593:247-253.
46. Frank PG, Pavlides S, Lisanti MP. 2009. Caveolae and transcytosis in endothelial cells: Role in atherosclerosis. Cell Tissue Res 335:41-47.
47. Arthur FE, Shivers RR, Bowman PD. 1987. Astrocyte-mediated induction of tight junctions in brain capillary endothelium: An efficient in vitro model. Brain Res 433:155-159.
48. Janzer RC, Raff MC. 1987. Astrocytes induce blood-brain barrier properties in endothelial cells. Nature 325:253-257.